Your browser doesn't support javascript.
loading
LncRNA: An Important Regulator of Atherosclerosis.
Ma, Yun; He, Siqi; Xie, Qiao; Tang, Zhihan; Jiang, Zhisheng.
Afiliación
  • Ma Y; Department of Biochemistry & Molecular Biology, Hengyang Medical School, University of South China, Hengyang, 421001, China.
  • He S; Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, Hunan International Scientific and Technological Cooperation Base of Arteriosclerotic Disease, Hengyang Medical School, University of South China, Hengyang, 421001, China.
  • Xie Q; Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang Medical School, University of South China, Hengyang, 421001, China.
  • Tang Z; Department of Biochemistry & Molecular Biology, Hengyang Medical School, University of South China, Hengyang, 421001, China.
  • Jiang Z; Department of Biochemistry & Molecular Biology, Hengyang Medical School, University of South China, Hengyang, 421001, China.
Curr Med Chem ; 30(38): 4340-4354, 2023.
Article en En | MEDLINE | ID: mdl-36635933
ABSTRACT
Long non-coding RNA (lncRNA) is a kind of biomolecule that can regulate important life activities such as cell proliferation, apoptosis, differentiation, aging, and body development. It has been found that lncRNAs are closely related to various diseases. In cardiovascular diseases, lncRNAs affect the expression level of related genes in atherosclerotic plaques, which are closely related to endothelial dysfunction, smooth muscle cell proliferation, macrophage dysfunction, abnormal lipid metabolism, and cellular autophagy, thus participating in regulating the occurrence and development of AS. In view of this, investigating the role of lncRNAs in regulating cardiac gene networks on cardiovascular system diseases has attracted much clinical attention and may be a novel target for AS therapy. This paper focuses on lncRNAs related to AS, explores the relationship between lncRNAs and AS, suggests the role of lncRNAs in the prevention and treatment of AS, and expects the application of more lncRNAs as the marker in the clinical diagnosis and treatment of AS.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Aterosclerosis / ARN Largo no Codificante Límite: Humans Idioma: En Revista: Curr Med Chem Asunto de la revista: QUIMICA Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Aterosclerosis / ARN Largo no Codificante Límite: Humans Idioma: En Revista: Curr Med Chem Asunto de la revista: QUIMICA Año: 2023 Tipo del documento: Article País de afiliación: China